C12N 2770/36241
Use of virus, viral particle or viral elements as a vector
C12N2770/36241 (Use of virus, viral particle or viral elements as a vector) appears on 4 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 5
- Assignees
- 6
- Inventors
- 13
- Latest grant
- 12 Sep 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year.
Subgroups
Granted patents
- C12N 2770/36243Viral genome or elements thereof as genetic vectorIndexing code4
- C12N 2770/36242Virus or viral particle as vehicleIndexing code0
- C12N 2770/36244Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2770/36245Special targeting system for viral vectorsIndexing code0
Recent patents
- Optically controlled virus protein, gene thereof, and virus vector containing said gene12 Sep 2023US 11,753,448 B2The University of Tokyo
- Live, attenuated rubella vector to express vaccine antigens14 Feb 2017US 9,566,329 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine10 Nov 2015US 9,181,306 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Polyvalent chimeric rubella virus-based vaccines11 Jun 2013US 8,460,680 B2National Health Research Institutes
- Flexible expression vector systems and application of same to vaccines and immunotherapeutics1 Aug 2024US 2024/0254515 A1The James Hutton Institute
- Optically controlled virus protein, gene thereof, and virus vector containing said gene25 Mar 2021US 2021/0087234 A1The University of Tokyo
- Live, attenuated rubella vector to express vaccine antigens19 Mar 2015US 2015/0079123 A1The United States of America, as represented by the Secretary, Dep. of Health and Human Services
- Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine16 Aug 2012US 2012/0207784 A1The United States of America, as represented by the Secretary, Department of Health and Human Services
- Polyvalent chimeric rubella virus-based vaccines28 Oct 2010US 2010/0272747 A1National Health Research Institutes
Most cited
By later US patents
- Polyvalent chimeric rubella virus-based vaccines4US 8,460,680 B2National Health Research Institutes · 2013
- Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine1US 9,181,306 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2015